1 recruiting. 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1 | Recruiting 1 |
Follow Daniel Coury: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AWARE: Management of ADHD in Autism Spectrum Disorder Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant. - ADHD, Autism Spectrum Disorder | Phase 4 | Recruiting | Daniel Coury | 500 | 2023-10-01 | 2026-10-22 |
Attention Deficit Disorder with Hyperactivity (1) · Autism Spectrum Disorder (1) · Autistic Disorder (1)
5,10-dihydro-5-methylphenazine (1) · Adenosine Monophosphate (1) · Methylphenidate (1)
Canada (1) · United States (1)